PD L1 News and Research

RSS
AI could make doctors’ work simpler, faster, and more precise

AI could make doctors’ work simpler, faster, and more precise

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Immune checkpoint therapy may be beneficial in certain cases of severe COVID-19

Immune checkpoint therapy may be beneficial in certain cases of severe COVID-19

Researchers circumvent a key mechanism in castration-resistant prostate cancer

Researchers circumvent a key mechanism in castration-resistant prostate cancer

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

Research could lead to a new therapeutic option for patients with bladder cancer

Research could lead to a new therapeutic option for patients with bladder cancer

Researchers synthesize a small molecule that can be used to treat a range of cancers

Researchers synthesize a small molecule that can be used to treat a range of cancers

First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy

Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy

Genetic signatures may help predict immunotherapy response in patients with bladder cancer

Genetic signatures may help predict immunotherapy response in patients with bladder cancer

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

Cytokine-based cancer immunotherapy: current progress and future prospects

Cytokine-based cancer immunotherapy: current progress and future prospects

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

Researchers fabricate highly-sensitive SERS probes to detect the PD-L1 biomarker

Researchers fabricate highly-sensitive SERS probes to detect the PD-L1 biomarker

New study looks at the role of beta cells in triggering autoimmunity

New study looks at the role of beta cells in triggering autoimmunity

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says